What is the role of intravenous ascorbic acid in the management of pancreatic cancer?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Intravenous ascorbic acid shows promise as an adjunctive therapy in pancreatic cancer, but further large-scale trials are necessary to clearly define its efficacy and safety profile.

Fields of Study & Subjects

Vitamin C and Antioxidants Research Pancreatic and Hepatic Oncology Research Pancreatitis Pathology and Treatment

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 March 2026
Language
EN